Roche Pharmaceutical Inc., et al.; Withdrawal of Approval of 13 New Drug Applications

Özet

The Food and Drug Administration (FDA) is withdrawing approval of 13 new drug applications (NDA's). The holders of the NDA's notified the agency in writing that the drug products were no longer being marketed under the NDA and requested that the approval of the applications be withdrawn.